Skip to Content

LCE 75 (Carbidopa, Entacapone and Levodopa 18.75 mg / 200 mg / 75 mg)

Pill with imprint LCE 75 is Red, Elliptical / Oval and has been identified as Carbidopa, Entacapone and Levodopa 18.75 mg / 200 mg / 75 mg. It is supplied by Sandoz Inc.

Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 18.75 mg / 200 mg / 75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LCE 75

Carbidopa, entacapone and levodopa 18.75 mg / 200 mg / 75 mg LCE 75

Carbidopa, Entacapone and Levodopa

Imprint
LCE 75
Strength
18.75 mg / 200 mg / 75 mg
Color
Red
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Inc

Labelers / Repackagers

NDC CodeLabeler / Repackager
00781-5625 Sandoz Inc.
00078-0544 Novartis Pharmaceuticals Corporation

Get help with Imprint Code FAQs.

Related Images for "LCE 75"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.